2 hours Leerink Partnrs Issues Pessimistic Outlook for ITCI EarningsMarketBeat
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) – Equities researchers at Leerink Partnrs dropped their Q3 2024 EPS estimates for shares of Intra-Cellular Therapies in a note issued to investors on Tuesday, October 15th. Leerink Partnrs a…
Earnings · Nasdaq 100 · Science
X